Abstract:With the ongoing mutation of SARS‐CoV‐2 leading to variants such as Alpha, Beta, Gamma, Delta and Omicron, there is an urgent need for new diagnostic methods for SARS‐CoV‐2 infection. Given the prevalence of the Omicron variant since 2022, the authors develop a MALDI‐TOF‐based diagnosis method with nasal swab samples and machine learning techniques to detect the infection by this variant. Based on the evaluation with 325 SARS‐CoV‐2 positive and 221 SARS‐CoV‐2 negative nasal swab samples, the results suggest that the MALDI‐TOF MS‐based nasal swab analysis holds effective diagnostic capabilities of SARS‐CoV‐2 infection, and shows promising potential for global application and extension to other infectious diseases. With the ongoing mutation of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) leading to various variants, there is an urgent need for new diagnostic methods for SARS‐CoV‐2 infection. The existing nucleic acid test and antigen test suffer from long assay time and low sensitivity, respectively. Matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS)‐based nasal swabs analysis have been demonstrated as a promising technique in SARS‐CoV‐2 infection screening. However, the applicability of the technique in the different variants of SARS‐CoV‐2 is uncertain. Given the prevalence of the Omicron variant since 2022, we developed a MALDI‐TOF‐based diagnosis method with nasal swab samples to detect the infection by this variant. We collected 325 SARS‐CoV‐2‐positive and 221 SARS‐CoV‐2‐negative nasal swab samples, and the molecular mass fingerprints were acquired from the samples by MALDI‐TOF MS. Using a random forest machine learning classification model to analyze the molecular mass fingerprints MALDI‐TOF mass spectra, the accuracy of 97%, false negative rate of 0%, and false positive rate of 7.6% were achieved for the diagnosis of SARS‐CoV‐2 infection. Combining the MALDI‐TOF analysis with top‐down proteomics, we identified four potential protein biomarkers, that is, humanin‐like 4, thymosin beta‐10, thymosin beta‐4 and statherin, in the nasal swab for the diagnosis of coronavirus disease 2019. It was further found that the four protein biomarkers can also differentiate the SARS‐CoV‐2 original strains infection and Omicron strains infection. These results suggest that the MALDI‐TOF MS‐based nasal swab analysis holds effective diagnostic capabilities of SARS‐CoV‐2 infection, and shows promising potential for global application and extension to other infectious diseases.

MALDI(+) FT-ICR Mass Spectrometry (MS) Combined with Machine Learning toward Saliva-Based Diagnostic Screening for COVID-19

Detection of SARS-CoV-2 in nasal swabs using MALDI-MS

Validation of a MALDI-TOF MS Method for SARS-CoV-2 Detection on the Bruker Biotyper and Nasopharyngeal Swabs: A Brazil-UK Collaborative Study

SG-APSIC1053: Detection of SARS-COV-2 in nasopharyngeal swags with MALDI-TOF MS and machine learning

Optimization and Standardization of Human Saliva Collection for MALDI-TOF MS

Application of Multiplex PCR Coupled with Matrix-Assisted Laser Desorption Ionization–Time of Flight Analysis for Simultaneous Detection of 21 Common Respiratory Viruses

Novel application of automated machine learning with MALDI-TOF-MS for rapid high-throughput screening of COVID-19: a proof of concept

Liquid saliva-based Raman spectroscopy device with on-board machine learning detects COVID-19 infection in real-time

MALDI‐TOF MS analysis of nasal swabs for the characterization of patients infected with SARS‐CoV‐2 Omicron

Rapid Detection of COVID-19 Using MALDI-TOF-Based Serum Peptidome Profiling

Detection of SARS-CoV-2 Infection in Human Nasopharyngeal Samples by Combining MALDI-TOF MS and Artificial Intelligence

Identification of Endogenous Peptides in Nasal Swab Transport Media used in MALDI-TOF-MS Based COVID-19 Screening.

Saliva as a Biological Fluid in SARS-CoV-2 Detection

RT-PCR/MALDI-TOF mass spectrometry-based detection of SARS-CoV-2 in saliva specimens

Mass Spectrometry-Based Metabolomics Reveals a Salivary Signature for Low-Severity COVID-19

Surface-Enhanced Raman Scattering Combined with Machine Learning for Rapid and Sensitive Detection of Anti-SARS-CoV-2 IgG

An Explainable-AI approach for Diagnosis of COVID-19 using MALDI-ToF Mass Spectrometry

Molecular fingerprint by omics-based approaches in saliva from patients affected by SARS-CoV-2 infection

Infrared Based Saliva Screening Test for COVID‐19

Machine Learning for COVID-19 Determination Using Surface-Enhanced Raman Spectroscopy

ATR-FTIR spectrum analysis of saliva samples from COVID-19 positive patients